Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Marius, Trøseid"'
Publikováno v:
Microbiome, Vol 12, Iss 1, Pp 1-16 (2024)
Abstract Background Despite modern antiretroviral therapy (ART), people living with HIV (PLWH) have increased relative risk of inflammatory-driven comorbidities, including cardiovascular disease (CVD). The gut microbiome could be one of several drivi
Externí odkaz:
https://doaj.org/article/8326a0c83c834dfea8e8771bb010e793
Publikováno v:
Open Heart, Vol 11, Iss 2 (2024)
Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal mucosa and disrupt its barrier function. This could facilitate the leakage of bacterial products into circulation and contribute
Externí odkaz:
https://doaj.org/article/3f370007134048568ddf9fe77db92e98
Autor:
Sarah Louise Murphy, Nora Reka Balzer, Trine Ranheim, Ellen Lund Sagen, Camilla Huse, Vigdis Bjerkeli, Annika E. Michelsen, Ane-Kristine Finbråten, Lars Heggelund, Anne Ma Dyrhol-Riise, Anders Tveita, Aleksander Rygh Holten, Marius Trøseid, Thor Ueland, Thomas Ulas, Pål Aukrust, Andreas Barratt-Due, Bente Halvorsen, Tuva Børresdatter Dahl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
There is a reciprocal relationship between extracellular matrix (ECM) remodelling and inflammation that could be operating in the progression of severe COVID-19. To explore the immune-driven ECM remodelling in COVID-19, we in this explorative study a
Externí odkaz:
https://doaj.org/article/eb392c9a5c874c078e333b5c9a1b811a
Autor:
Sajan C. Raju, Antonio Molinaro, Ayodeji Awoyemi, Silje F. Jørgensen, Peder R. Braadland, Andraz Nendl, Ingebjørg Seljeflot, Per M. Ueland, Adrian McCann, Pål Aukrust, Beate Vestad, Cristiane Mayerhofer, Kaspar Broch, Lars Gullestad, Knut T. Lappegård, Bente Halvorsen, Karsten Kristiansen, Johannes R. Hov, Marius Trøseid
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-12 (2024)
Abstract Background Interactions between the gut microbiota, diet, and host metabolism contribute to the development of cardiovascular disease, but a firm link between disease-specific gut microbiota alterations and circulating metabolites is lacking
Externí odkaz:
https://doaj.org/article/61d1247a5e1f4aefba1ffb6bb0b763c7
Autor:
Thale D. J. H. Patrick-Brown, Josephine Bourner, Sabrina Kali, Marius Trøseid, Yazdan Yazdanpanah, Piero Olliaro, Inge Christoffer Olsen
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background The new European Medicines Agency (EMA) Clinical Trials Information System (CTIS), based on the Clinical Trials Regulation (CTR EU 536/2014), came into full effect on 31 January 2022 and was intended to provide an easier, more str
Externí odkaz:
https://doaj.org/article/e24fdd6e1d9c485bb7e2712580f63323
Autor:
Hedda Hoel, Tuva Børresdatter Dahl, Kuan Yang, Linda Gail Skeie, Annika Elisabet Michelsen, Thor Ueland, Jan Kristian Damås, Anne Ma Dyrhol-Riise, Børre Fevang, Arne Yndestad, Pål Aukrust, Marius Trøseid, Øystein Sandanger
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7141 (2024)
Antiretroviral treatment (ART) has converted HIV from a lethal disease to a chronic condition, yet co-morbidities persist. Incomplete immune recovery and chronic immune activation, especially in the gut mucosa, contribute to these complications. Infl
Externí odkaz:
https://doaj.org/article/2082d071afd1473c96cbdea9fab7a235
Autor:
Marius Trøseid, Jan Cato Holter, Kristian Holm, Beate Vestad, Taisiia Sazonova, Beathe K. Granerud, Anne Ma Dyrhol-Riise, Aleksander R. Holten, Kristian Tonby, Anders Benjamin Kildal, Lars Heggelund, Anders Tveita, Simen Bøe, Karl Erik Müller, Synne Jenum, Johannes R. Hov, Thor Ueland, Norwegian SARS-CoV-2 study group
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-9 (2023)
Abstract Background Gut microbiota alterations have been reported in hospitalized COVID-19 patients, with reduced alpha diversity and altered microbiota composition related to respiratory failure. However, data regarding gut microbiota and mortality
Externí odkaz:
https://doaj.org/article/91ee7efa14f5474e8a0b0a0a1645e243
Autor:
Marius Trøseid, José R. Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, Vida Terzić, Fulvia Mazzaferri, Jesús Rodríguez Baño, Joe Eustace, Maya Hites, Michael Joannidis, José-Artur Paiva, Jean Reuter, Isabel Püntmann, Thale D. J. H. Patrick-Brown, Elin Westerheim, Katerina Nezvalova-Henriksen, Lydie Beniguel, Tuva Børresdatter Dahl, Maude Bouscambert, Monika Halanova, Zoltán Péterfi, Sotirios Tsiodras, Michael Rezek, Matthias Briel, Serhat Ünal, Martin Schlegel, Florence Ader, Karine Lacombe, Cecilie Delphin Amdal, Serge Rodrigues, Kristian Tonby, Alexandre Gaudet, Lars Heggelund, Joy Mootien, Asgeir Johannessen, Jannicke Horjen Møller, Beatriz Diaz Pollan, Anders Aune Tveita, Anders Benjamin Kildal, Jean-Christophe Richard, Olav Dalgard, Victoria Charlotte Simensen, Aliou Baldé, Lucie de Gastines, Marta del Álamo, Burç Aydin, Fridtjof Lund-Johansen, Mary-Anne Trabaud, Alpha Diallo, Bente Halvorsen, John-Arne Røttingen, Evelina Tacconelli, Yazdan Yazdanpanah, Inge C. Olsen, Dominique Costagliola, EU SolidAct study group
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-15 (2023)
Abstract Background Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. Methods Bari-SolidAct is a phase-3, mul
Externí odkaz:
https://doaj.org/article/10e2b9214bb042eab664227ef6ea4d9d
Autor:
Kristine Stø, Jørgen Valeur, Thor Ueland, Gunn Helen Malmstrøm, Vigdis Bjerkeli, Marius Trøseid, Johannes R. Hov, Kristian Holm, Beate Vestad, Bente Halvorsen, Mona Skjelland, Karolina R. Skagen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The short-chain fatty acid (SCFA) butyric acid maintains a healthy gut barrier and vascular endothelium. We aimed to investigate the association between fecal butyric acid, carotid atherosclerosis and risk factors for ischemic stroke. Patien
Externí odkaz:
https://doaj.org/article/53d3e81101574bb6a7ebc21d9c59ca93
Autor:
Andraž Nendl, Sajan C. Raju, Kaspar Broch, Cristiane C. K. Mayerhofer, Kristian Holm, Bente Halvorsen, Knut Tore Lappegård, Samuel Moscavitch, Johannes Roksund Hov, Ingebjørg Seljeflot, Marius Trøseid, Ayodeji Awoyemi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundThe gut microbiota in patients with chronic heart failure (HF) is characterized by low bacterial diversity and reduced ability to synthesize beneficial metabolites. These changes may facilitate leakage of whole bacteria or bacterial product
Externí odkaz:
https://doaj.org/article/8d10a313240f47f88c7a5c2ddbedbcfc